The shares of this large-cap compnay jumped around 2 percent after launching a generic formulation to treat ovarian cancer in the United States. The stock has delivered around 70 percent return to its shareholders on a YTD basis.  Price Movement:  With a market capitalization of Rs. 1,02,129 crores, the shares of Lupin Ltd started Friday’s … Continue reading Pharma stock jumps after launching cancer treatment drug in US; Receives share target